Genmab A/S (GMAB)

Genmab Revenue

Genmab had revenue of $2.44B in the twelve months ending December 31, 2023, with 16.77% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $693.04M, a -6.37% decrease year-over-year. In the year 2022, Genmab had annual revenue of $2.09B with 63.89% growth.

• Revenue (ttm): $2.44B
• Revenue Growth: +16.77%
• P/S Ratio: 7.61
• Revenue / Employee: $1,107,347
• Employees: 2,204
• Market Cap: 18.80B USD

Revenue Chart

* The company reports in DKK currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	2.09B	814.75M	63.89%
Dec 31, 2021	1.28B	-382.24M	-23.06%
Dec 31, 2020	1.66B	856.65M	106.96%
Dec 31, 2019	800.90M	336.94M	72.62%
Dec 31, 2018	463.96M	82.65M	21.68%
Dec 31, 2017	381.30M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.